Volume 16, Number 11—November 2010
Experimental Pandemic (H1N1) 2009 Virus Infection of Cats
Highlight and copy the desired format.
|EID||van den Brand J, Stittelaar KJ, van Amerongen G, van de Bildt MW, Leijten LM, Kuiken T, et al. Experimental Pandemic (H1N1) 2009 Virus Infection of Cats. Emerg Infect Dis. 2010;16(11):1745-1747. https://dx.doi.org/10.3201/eid1611.100845|
|AMA||van den Brand J, Stittelaar KJ, van Amerongen G, et al. Experimental Pandemic (H1N1) 2009 Virus Infection of Cats. Emerging Infectious Diseases. 2010;16(11):1745-1747. doi:10.3201/eid1611.100845.|
|APA||van den Brand, J., Stittelaar, K. J., van Amerongen, G., van de Bildt, M. W., Leijten, L. M., Kuiken, T....Osterhaus, A. (2010). Experimental Pandemic (H1N1) 2009 Virus Infection of Cats. Emerging Infectious Diseases, 16(11), 1745-1747. https://dx.doi.org/10.3201/eid1611.100845.|
To demonstrate that pandemic (H1N1) 2009 virus may cause respiratory disease in cats, we intratracheally infected cats. Diffuse alveolar damage developed. Seroconversion of sentinel cats indicated cat-to-cat virus transmission. Unlike in cats infected with highly pathogenic avian influenza virus (H5N1), extrarespiratory lesions did not develop in cats infected with pandemic (H1N1) 2009 virus.
Soon after pandemic (H1N1) 2009 virus emerged in North America, infections in domestic cats were reported (1,2). Infection with highly pathogenic avian influenza (HPAI) virus (H5N1) leads to severe and often fatal diffuse alveolar damage and systemic virus spread in cats (3–5). In contrast, seasonal human influenza viruses do not cause disease in cats (6). To elucidate the pathogenesis of pandemic (H1N1) 2009 virus infection in cats, we studied 8 laboratory cats intratracheally infected with this virus.
Pandemic (H1N1) 2009 virus (A/Netherlands/602/2009) was isolated from a 3-year-old girl from the Netherlands who had mild influenza after she visited Mexico in early 2009. Virus was cultured in embryonated chicken eggs and passaged once in MDCK cells (7).
We used 2 groups (4 cats/group) of 16-week-old, purpose-bred, specific pathogen–free, European shorthair cats that were seronegative for hemagglutination-inhibition (HI) antibodies against pandemic (H1N1) 2009 virus and circulating seasonal influenza A viruses. These cats were intratracheally infected with a 106.0 tissue culture infectious dose (TCID50) of pandemic (H1N1) 2009 virus. A third group of 3 sentinel cats were housed with these 2 infected groups (1 with group 1 and 2 with group 2) from 2 days postinfection (dpi) onward. Serum samples were obtained on 0, 4, 7, and 21 dpi and stored at –20°C until tested for HI antibodies against pandemic (H1N1) 2009 virus (8).
All 11 cats were monitored daily for clinical signs, and body temperature was measured at 15-min intervals. Nasal, pharyngeal, and rectal swab specimens were obtained daily from all cats. After being anesthetized with ketamine, all cats were killed by exsanguination. Cats in groups 1 and 2 were killed at 4 dpi and 7 dpi, respectively. Sentinel cats were killed at 21 dpi. Experiments were performed under BioSafety Level 3 by using protocols approved by our Institutional Animal Welfare Committee.
Necropsies were performed according to a standard protocol. Lung, nasal turbinate, nasal septum, larynx, trachea, bronchus, tracheobronchial lymph node, nictitating membrane, tonsil, heart, liver, spleen, kidney, pancreas, duodenum, jejunum, colon, adrenal gland, brain, and olfactory bulb samples were obtained, were fixed in formalin, and processed to obtain sections for staining with hematoxylin and eosin.
For detection of viral antigen, tissue sections were stained with viral nucleoprotein–specific antibody (6). Alveolar epithelial cells were phenotyped by using a destaining–restaining technique (9). After organ samples were weighed and stored at –80°C, infectious pandemic (H1N1) 2009 virus was quantified by limiting dilution virus isolation in MDCK cells (10).
Cats in groups 1 and 2 infected with pandemic (H1N1) 2009 virus showed mild-to-moderate clinical signs (lethargy, appetite loss, rapid and labored breathing, and protruding nictitating membrane) after 1 dpi or 2 dpi onwards. Average body temperatures increased after 1 dpi, showed a maximum increase of ≈1.5°C by 2 dpi, and returned to baseline values within 4–5 dpi (Figure). Sentinel cats showed no clinical signs. Two cats in group 1 (2 pharyngeal samples) and 2 cats in group 1 and 1 cat in group 2 (1 pharyngeal sample) had low virus titers during 1–4 dpi (<101.8 TCID50/g). Nasal swab specimens from all sentinel cats and pharyngeal and rectal swab specimens from 2 were virus positive by reverse transcription–PCR (cycle threshold >35) 2–6 days after first contact with infected cats. No virus was isolated from these swab specimens.
On 4 dpi, high virus titers were found in lungs, bronchi, and tracheas from 4 infected cats (105.5–6.3, 102.9–4.6, and 103.1–3.8 TCID50/g, respectively). Tonsils from 2 cats, intestines from 1 cat, and the spleen from 1 cat also had high virus titers (103.0, 104.2, 101.6, and 101.6 TCID50/g, respectively). On 7 dpi, virus was detected in lung from 1 cat and trachea from 1 cat (103.0 and 101.6 TCID50/g, respectively). Infectious virus (101.2–2.2 TCID50/g) was found in liver, intestine, brain, adrenal glands, and nictitating membranes of individual cats. The olfactory bulb of 1 cat was virus positive (103.0 TCID50/g). No other organs from any cats were virus positive (Table).
No serum HI antibodies (titer <20) were found in group 1 cats on 4 dpi. All group 2 cats had serum HI antibodies (titers 30–120) on 7 dpi. One sentinel cat was seropositive on 15 dpi (titer 40); all cats were positive on 21 dpi (titer 80).
All infected cats showed multifocal or coalescing pulmonary consolidation, ranging from 30% to 50% on 4 dpi and from 10% to 30% on 7 dpi (Technical Appendix [PDF - 144 KB - 2 pages]). All tracheobronchial lymph nodes were enlarged 3–5×. Palatine tonsils were enlarged ≈2× on 7 dpi. All sentinel cats showed mild multifocal consolidation; 5%–10% of lung parenchyma were affected. Two cats had tracheobronchial lymph nodes enlarged 2–5×.
Histopathologic analysis (Technical Appendix [PDF - 144 KB - 2 pages]) identified pulmonary consolidation indicative of diffuse alveolar damage. Alveolar and bronchiolar lumina showed edema and contained variable numbers of macrophages, neutrophils, and erythrocytes mixed with fibrin and cellular debris. Alveolar walls were thickened and showed necrosis of lining epithelium and type II pneumocyte hyperplasia.
Bronchiolar walls were moderately infiltrated by neutrophils and had multifocal epithelial necrosis and multifocal peribronchiolar moderate infiltration by macrophages and lymphocytes and few neutrophils and plasmacytes. Bronchial lumina harbored few neutrophils and scant edema, fibrin, and cellular debris. There were few peribronchial infiltrates with a small number of lymphocytes, plasmacytes, and macrophages. Lung lesions seen on 4 dpi and 7 dpi were comparable except for more extensive type II pneumocyte hyperplasia on 7 dpi. Tracheobronchial lymph nodes and palatine tonsils had severe sinus histiocytosis and lymphocytolysis and moderate infiltration by neutrophils. Histologic changes in lung parenchyma of all sentinel cats were consistent with chronic lesions resulting from those seen in the other cats. No lesions were seen in other organs of all cats.
Virus antigen expression was more prominent on 4 dpi than on 7 dpi and was closely associated with histologic lesions (Technical Appendix [PDF - 144 KB - 2 pages]). Virus antigen expression was seen in many type II pneumocytes, few type I pneumocytes, alveolar macrophages, bronchiolar ciliated and nonciliated epithelial cells, and rare bronchial ciliated epithelial cells. Type I and II pneumocytes were identified by double-staining with cytokeratin. No virus antigen was observed in sentinel cats.
Intratracheal infection of domestic cats with pandemic (H1N1) 2009 virus resulted in mild-to-moderate clinical signs and virus replication throughout the respiratory tract, which caused diffuse alveolar damage. The pathogenesis in the respiratory tract in cats was similar to that occurring in humans, macaques, and ferrets (7,11–13). Seroconversion of sentinel cats indicated cat-to-cat transmission.
Unlike infection with seasonal human influenza viruses, infection with pandemic (H1N1) 2009 virus causes respiratory disease in cats. To compare infections with these viruses, we used our unpublished data for cats intratracheally infected with 105.0 TCID50 of HPAI virus (H5N1) (A/Indonesia/5/05) at 4 dpi and 7 dpi (4) and for sham-infected cats. Histopathologic and immunohistochemical findings in lungs of cats infected with these viruses coincided, which indicated a similar pathogenetic process and increased severity in cats infected with HPAI virus (H5N1). However, in contrast to HPAI virus (H5N1), pandemic (H1N1) 2009 virus does not cause extrapulmonary lesions in infected cats. Our data show that pandemic (H1N1) 2009 virus may cause respiratory disease in cats and that human-to-cat transmission is the most likely route of infection.
Dr van den Brand is a veterinary pathologist and PhD candidate in the Department of Virology at Erasmus Medical Centre, Rotterdam, the Netherlands. Her research interest focuses on the pathology of respiratory virus infections in different species.
We thank P. van Run, R. Verbeek, and L. de Waal for technical assistance; W. Vos for biotechnical assistance; and F. van der Panne for preparing the figure.
- Sponseller BA, Strait E, Jergens A, Trujillo J, Harmon K, Koster L, Influenza pandemic (H1N1) 2009 virus infection in domestic cat. Emerg Infect Dis. 2010;16:534–7.
- Löhr CV, DeBess EE, Baker RJ, Hiett SL, Hoffman KA, Murdoch VJ, Pathology and viral antigen distribution of lethal pneumonia in domestic cats due to pandemic (H1N1) 2009 influenza A virus. Vet Pathol. 2010;47:378–86.
- Keawcharoen J, Oraveerakul K, Kuiken T, Fouchier RA, Amonsin A, Payungporn S, Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis. 2004;10:2189–91.
- Rimmelzwaan GF, van Riel D, Baars M, Bestebroer TM, van Amerongen G, Fouchier RA, Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol. 2006;168:176–83.
- Desvaux S, Marx N, Ong S, Gaidet N, Hunt M, Manuguerra JC, Highly pathogenic avian influenza virus (H5N1) outbreak in captive wild birds and cats, Cambodia. Emerg Infect Dis. 2009;15:475–8.
- Kuiken T, Rimmelzwaan G, van Riel D, van Amerongen G, Baars M, Fouchier R, Avian H5N1 influenza in cats. Science. 2004;306:241.
- Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, Pathogenesis and transmission of swine-origin 2009 A/H1N1 influenza virus in ferrets. Science. 2009;325:481–3.
- Palmer DF, Dowdle WR, Coleman MT, Schild GC. Hemagglutination inhibition test. Advanced laboratory techniques for influenza diagnosis. Procedural guide. Atlanta: Center for Disease Control; 1975. p. 25–62.
- Deng R, Lu M, Korteweg C, Gao Z, McNutt MA, Ye J, Distinctly different expression of cytokines and chemokines in the lungs of two H5N1 avian influenza patients. J Pathol. 2008;216:328–36.
- Rimmelzwaan GF, Baars M, Claas EC, Osterhaus AD. Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro. J Virol Methods. 1998;74:57–66.
- van den Brand JM, Stittelaar KJ, van Amerongen G, Rimmelzwaan GF, Simon J, de Wit E, Severity of new H1N1 influenza pneumonia in ferrets intermediate between that of seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis. 2010;201:993–9.
- Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature. 2009;460:1021–5.
- Taubenberger JK, Morens DM. The pathology of influenza virus infections. Annu Rev Pathol. 2008;3:499–522.
- Figure. Average body temperatures of 2 groups of cats experimentally infected with pandemic (H1N1) 2009 virus (groups 1 and 2) and sentinel cats (group 3).
Technical AppendixCite This Article
Please use the form below to submit correspondence to the authors or contact them at the following address:
Albert D.M.E. Osterhaus, Department of Virology, Erasmus Medical Centre, Dr Molewaterplein 50, 3015 GE Rotterdam, the Netherlands
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: March 08, 2011
- Page last updated: March 08, 2011
- Page last reviewed: March 08, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)